INS and metabolic dysfunction-associated steatotic liver disease: Given the close relationship between IR and NAFLD, indicators of IR, such as fasting blood glucose (FBG), fasting insulin, and the homeostasis model assessment of insulin resistance (HOMA-IR), have been widely used as biomarkers to assess metabolic dysfunction in patients with NAFLD (7, 8).